Faegre Drinker Biddle & Reath LLP, a Delaware limited liability partnership | This website contains attorney advertising.
August 27, 2020

White House Targets Drug Pricing, Importation Through Executive Action

Partner Libby Baney and director Matthew Rubin co-authored an article for The National Association of Boards of Pharmacy titled “White House Targets Drug Pricing, Importation Through Executive Action,” regarding a series of executive orders focusing on longstanding priorities intended to drive prescription drug costs down.

The orders outline four key priority areas, including increasing drug importation from foreign countries; eliminating kickbacks to pharmacy benefits managers; improved access and affordability of insulin and epinephrine; and reducing the costs associated with prescription drugs dispensed under the Medicare Part B program.

The latest of these orders focuses on combating the trafficking of counterfeit products via online search and social platforms and third-party sellers. Recognizing the scope of this order, Baney and Rubin encourage regulators, patients and the industry to be extra vigilant against the risks of substandard, falsified, counterfeit and diverted medicines and devices, and other products entering the U.S. drug supply.

Full Article

The Faegre Drinker Biddle & Reath LLP website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Drinker Biddle & Reath LLP's cookies information for more details.